Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.
Purity:
98.0%
CAS Number:
[1879925-92-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted